Search

The author discusses the paper by C. Stemberger and colleagues entitled, "Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy." He mentions that the researchers demonstrated that CD62Lhi antigen-specific T cells are more persistent than more differentiated CD62Llo cells. He suggests the efforts of the researchers should be expanded to enable cellular therapies to be part of medical practice.